黑料网

Journal of Oncology Research and Treatment
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Oncol Res Treat, Vol 4(1): 1 (128)

Does Age Affect the Outcomes of Translocation Renal Cell Carcinoma? A Retrospective Analysis from A Middle Eastern Cohort

Ali Al-Daghmin*, Sohaib Alhamss, Weam Al-Qasem, Khloud Al-Qasem, Lujain Al-Omari, Hani Al-Najjar and Duaa DAhbour
Department of Surgery, King Hussein Cancer Center Surgery, Jordan
*Corresponding Author : Ali Al-Daghmin, Urologic Oncology & Robotic Surgery Consultant, Surgery Department, King Hussein Cancer Center, Jordan, Tel: 00962798917748, Email: A_daghamin@hotmail.com

Received Date: Dec 24, 2018 / Accepted Date: Dec 31, 2018 / Published Date: Jan 07, 2019

Abstract

Background: The natural history of Translocation renal cell carcinomas (tRCC) is variable from indolent behaviors to aggressive disease that demonstrates lymph node and widespread metastasis. Translocation renal cell carcinomas (TRCC) represent 1% to 5% of all cases of renal cell carcinoma (RCC).

Objectives: We sought to characterize the associations between age at presentation of tRCC patients and stage, grade, survival and recurrence of the disease in Middle Eastern institution. Materials and methods: Retrospective review of clinical and pathological data from a single institution for 23 patients diagnosed with tRCC between 2005 and 2017. Patients were categorized into two group based on age group 1 (>40 years) and group 2 (≤ 40 years). We evaluated the association between tumor grade, gender, disease free survival (DFS), overall survival (OS) and age.

Results: The tumor was on the right kidney in 52.2% of the patients, and bilateral in one patient. Ten patients (43.5%) were above 40 years of age, and 13 patients (56.5%) were less than or equal to 40 years old regarding the tumor characteristics, the mean tumor size was 9 cm; 4 patients (17.3%) had pathologic T1, seven patients (30.4%) had pathologic T2, 10 patients (43.4%) had pathologic T3 or more and two patients (8.7%) had no surgery. Eleven patients (47.8%) had lymph node dissection for clinically enlarged lymph nodes and seven (64%) of them had lymph nodes metastasis. Nineteen patients (83%) underwent radical nephrectomy and two (8%) had partial nephrectomy. Bilateral renal tumors were managed with left radical and right partial nephrectomy. There were no differences in DFS in patients above and below 40 years of age. No statistically significant associations between Disease-Free survival, gender, pathologic T staging, overall survival and age.

Conclusion: tRCC has variable clinical behavior from indolent to aggressive disease. Age may not affect this clinical behavior.

Keywords: Renal cell carcinoma; Translocation renal cell carcinomas; Microphthalmia-associated transcription

Citation: Al-Daghmin A, Alhamss S, Al-Qasem W, Al-Qasem K, Al-Omari L, et al.(2019) Does Age Affect the Outcomes of Translocation Renal Cell Carcinoma? A Retrospective Analysis from A Middle Eastern Cohort J Oncol Res Treat 4: 128.

Copyright: © 2019 Al-Daghmin A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top